Pulse ·

Menopause brain fog is real — and GPs are getting a roadmap

By Dr HB Lo, FACRRM 4 min read
Verdict Yes — worth knowing about

Many women in perimenopause and menopause experience cognitive symptoms — memory lapses, word-finding failures, difficulty concentrating — that are clinically real and linked to oestrogen fluctuation and sleep disruption. A new clinical guide for GPs, published this week in AusDoc by Monash University researchers, gives practitioners a framework to assess and manage these symptoms. Hormone therapy and sleep optimisation are among the evidence-supported options; GP assessment is the appropriate starting point.

What just happened

A new clinical guide on cognitive disturbance in menopause — authored by Associate Professor Caroline Gurvich and Dr Marita Long from Monash University’s Women’s Mental Health research group — was published this week in AusDoc as a CPD-accredited Therapy Update, carrying 0.5 EA credits for Australian GPs.

The guide describes menopausal cognitive symptoms as a “historically under-acknowledged phenomenon” in clinical practice. That framing is telling. If you have been to a GP with complaints of memory lapses, difficulty concentrating, or losing words mid-sentence — and been told it is probably stress, or anxiety, or just getting older — this resource represents the mainstream medical profession taking a clearer position.

Cognitive symptoms are among the most common, most distressing, and least discussed aspects of the perimenopause and menopause transition. Unlike hot flushes, they are invisible to anyone but the woman experiencing them. Unlike sleep disruption, they are hard to measure objectively. And because they are subjective, they have been disproportionately dismissed — or absorbed into a depression or anxiety diagnosis that may not be the full picture.

The both-and

The evidence base is real

Jean Hailes for Women’s Health — one of Australia’s leading women’s health authorities — notes that cognitive complaints are widely reported in women navigating the menopause transition. Research links these symptoms to the hormonal biology of perimenopause, not only to psychological stress or normal ageing.

Oestrogen has widespread effects in the brain. Oestrogen receptors are distributed throughout the hippocampus (central to memory formation) and prefrontal cortex (central to executive function and concentration). During perimenopause — the years leading up to the final menstrual period, which can span four to ten years — oestrogen levels fluctuate significantly before eventually declining. It is this fluctuation phase, rather than the sustained low levels of post-menopause, that appears to drive many of the cognitive symptoms women report.

Sleep disruption is a major mediator. Vasomotor symptoms — hot flushes and night sweats — frequently interrupt sleep, and chronic sleep disruption reliably impairs memory, concentration, and word retrieval. For women whose cognitive symptoms co-occur with night sweats, sleep is often the most direct route into the problem.

Mood changes add further complexity. Anxiety and depression both peak in frequency during the perimenopause transition and independently impair cognitive function. Distinguishing between a mood disorder causing cognitive symptoms, a sleep disorder causing cognitive symptoms, and a more direct hormonal effect on the brain requires careful clinical assessment — precisely what the AusDoc guide aims to equip GPs to do.

What makes this hard to study

The cognitive symptoms of perimenopause sit at an inconvenient clinical intersection: they arrive at the same age at which normal age-related cognitive changes begin, mood disorders peak in women, and sleep quality often declines for non-hormonal reasons.

Separating oestrogen-mediated cognitive change from these confounders in randomised trials is difficult. This partly explains why the evidence base for specific treatments is more mixed than for vasomotor symptoms. The trial data on hormone therapy and cognitive outcomes shows benefit — particularly when therapy is initiated early in the perimenopause transition, the so-called “critical window” — but is less consistent in women who begin therapy years after menopause.

The Australasian Menopause Society acknowledges cognitive symptoms as a legitimate aspect of menopausal experience that warrants clinical attention and an individualised management plan.

What the clinical guide offers

The value of the AusDoc guide is structural: it gives GPs a framework to take these presentations seriously and work through them systematically. That means differentiating cognitive symptoms from mood disorders and sleep disorders; identifying the timing of symptoms relative to the menopause transition; and discussing options with the patient.

Management approaches include menopausal hormone therapy (MHT) for eligible women — which reliably improves vasomotor symptoms and sleep, and may have direct cognitive benefits when initiated early; sleep optimisation; and treatment of co-occurring mood symptoms. Lifestyle factors, particularly regular aerobic and resistance exercise, have documented benefit for both cognitive function and mood across the menopausal transition.

My two cents

If you are in your 40s and noticing that your memory, concentration, or word-finding have shifted — particularly alongside changes in your menstrual cycle, sleep, or mood — that is a clinical presentation worth naming explicitly at a GP appointment.

The existence of a CPD-accredited guide on this topic, authored by Monash researchers and published in a national medical journal, is meaningful. It signals that the GP profession is being equipped to take menopausal cognitive symptoms seriously. That is a recent shift, not a longstanding one.

What it means practically: name the symptoms clearly. “I have been struggling with my memory and concentration since my periods became irregular” is more useful than “I feel a bit off.” Your GP now has a structured roadmap to work from — but they need you to bring the presentation into the room.

If your GP is not yet familiar with the evidence, Jean Hailes for Women’s Health and the Australasian Menopause Society have patient and clinician resources you can share.

Verdict: yes — worth knowing about.

Sources cited

  1. Gurvich C, Long M. “A GP guide to cognitive disturbance in menopause.” AusDoc Therapy Update, 18 July 2026. https://www.ausdoc.com.au/therapy-update/a-gp-guide-to-cognitive-disturbance-in-menopause/
  2. Jean Hailes for Women’s Health. Menopause. https://jeanhailes.org.au/health-a-z/menopause
  3. Australasian Menopause Society. https://www.menopause.org.au

Frequently asked questions

  • Is menopause brain fog medically recognised?

    Yes. Subjective cognitive complaints — memory lapses, concentration failures, word-finding difficulty — are reported by a significant proportion of women during perimenopause and early menopause. Research links these symptoms to oestrogen fluctuation, sleep disruption from night sweats, and co-occurring mood changes. A new clinical guide for GPs, published in AusDoc this week, describes cognitive disturbance as a 'historically under-acknowledged' menopausal phenomenon that deserves assessment and management, not dismissal.

  • Can hormone therapy improve cognitive symptoms in menopause?

    The evidence is nuanced. Hormone therapy reliably improves vasomotor symptoms and sleep — and this can in turn improve cognitive symptoms mediated by poor sleep and mood disturbance. Some research also points to a more direct neuroprotective role of oestrogen when therapy is initiated early in the perimenopause transition. This is a clinical decision involving your full health profile; your GP is the right person to discuss whether hormone therapy suits your situation.